These data suggest that NEK2 may provide an ideal mitotic target for potentiating the efficacy of CDK4/6i and expanding their use in TNBC by promoting CIN and inducing mitotic cell death. This evidence concerns the gene CDK4 and cervical squamous intraepithelial neoplasia.